Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study-Reference-Cited by-同舟云学术

Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study

Published:2002-07-01 Issue:7 Volume:17 Page:1729-1737
ISSN:0268-1161
Container-title:Human Reproduction
language:en
Short-container-title:Human Reproduction

Author:

Elter K.,Imir G.,Durmusoglu F.

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Link

http://academic.oup.com/humrep/article-pdf/17/7/1729/9818725/171729.pdf

Reference50 articles.

1. Can metformin reduce insulin resistance in polycystic ovary syndrome?**Presented in part at the 31st Annual Meeting of The European Association for the Study of Diabetes, Stockholm, Sweden, September 12 to 16, 1995.

2. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

3. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

4. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome

5. Metformin directly inhibits androgen production in human thecal cells

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycystic ovary syndrome: Current scenario and future insights;Drug Discovery Today;2023-12

2. Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis;The Journal of Clinical Endocrinology & Metabolism;2023-08-09

3. Oral contraceptives (OCs) in combination with metformin versus OCs alone on metabolism in nonobese polycystic ovary syndrome: A meta‐analysis and systematic review of randomized controlled trials;Clinical Endocrinology;2023-04-07

4. Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women;BMC Women's Health;2023-02-15

5. Hirsutism, Normal Androgens and Diagnosis of PCOS;Diagnostics;2022-08-09